Abstract

Previous studies have demonstrated that extracorporeal shock wave therapy (ESWT) could accelerate diabetic wound healing and that the inhibition of glycogen synthase kinase-3β (GSK-3β) is involved in epithelial differentiation during wound healing. This study investigated whether the enhancement of diabetic wound healing by ESWT is associated with the GSK-3β-mediated Wnt/β-catenin signaling pathway. A dorsal skin wounding defect model using streptozotocin-induced diabetic rodents was established. Rats were divided into 4 groups: group 1, normal controls without diabetes; group 2, diabetic controls without treatment; group 3, diabetic rats receiving ESWT; and group 4, rats receiving 6-bromoindirubin-3′oxime (BIO), a GSK-3β inhibitor, to trigger Wnt/β-catenin signaling. Tissue samples were collected and analyzed by immunohistochemical (IHC) staining and quantitative RT-PCR. The ESWT and BIO-treated groups both exhibited significant promotion of wound healing compared to the healing in controls without treatment. RT-PCR analysis of Wnt-1, -3a, -4, -5a, and -10 and β-catenin expression showed significantly increased expression in the ESWT group. The IHC staining showed that Wnt-3a and -5a and β-catenin levels were significantly increased in the ESWT and BIO treatment groups compared to the control groups. ESWT enhancement of diabetic wound healing is associated with modulation of the GSK-3β-mediated Wnt/β-catenin signaling pathway.

Highlights

  • The in vivo results revealed that the size of the wound margin was significantly decreased in the extracorporeal shock wave therapy (ESWT)- and bromoindirubin-3 oxime (BIO)-treated diabetic groups compared with the diabetic control group (Figure 1a)

  • The results indicated that both ESWT and BIO enhanced diabetic wound healing

  • Wnt10 had an increasing trend, but the differences were not significant. These results demonstrated that ESWT enhanced diabetic wound healing and that wound healing was associated with the Wnt/β-catenin signaling pathway

Read more

Summary

Introduction

Appropriate wound treatments include aggressive debridement, infection control, pressure offloading, and modern wound dressing [2]. Numerous therapeutic approaches have been developed to improve wound healing, such as hyperbaric oxygen therapy and negative pressure wound therapy [3]. These therapeutic options are useful adjuncts to standard treatment, some treatment outcomes remain unclear [4,5,6]. Extracorporeal shockwave therapy (ESWT) acts as a physical stimulus that promotes biological healing processes through mechanotransduction.

Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.